Cognitive Function
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
1 programTranscranial Magnetic StimulationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Colorado TherapeuticsTranscranial Magnetic Stimulation
Cognition TherapeuticsDCTclock
Human BioSciencesKrill oil capsules
Clinical Trials (3)
Total enrollment: 816 patients across 3 trials
Brain Stimulation Effects on Cognitive Task Performance
Start: Apr 2023Est. completion: Jan 2028100 patients
N/ARecruiting
Evaluation of DCTclock™ as a Cognitive Assessment Aid
Start: Jul 2017Est. completion: Nov 2017450 patients
N/ACompleted
Effect of Omega-3 LCPUFA Intervention on Learning, Cognition, Behaviour and Visual Processing.
Start: Jan 2014Est. completion: Aug 2016266 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 816 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.